Revvity, Inc. (NYSE:RVTY) stock rose Tuesday after the life sciences and diagnostics company released preliminary expectations for the fourth quarter and fiscal year 2025. The positive movement comes despite broader market pressure, with major indices like the Nasdaq and S&P 500 both slightly…
Continue reading...